Cognitive deficits in Parkinson's disease (PD) are heterogeneous and can be classified into cognitive domains. Quantitative EEG is related to and predictive of cognitive status in PD. In this cross-sectional study, the relationship of cognitive domains and EEG slowing in PD patients without dementia is investigated.; A total of 48 patients with idiopathic PD were neuropsychologically tested. Cognitive domain scores were calculated combining Z-scores of test variables. Slowing of EEG was measured with median EEG frequency. Linear regression was used for correlational analyses and to control for confounding factors.; EEG median frequency was significantly correlated to cognitive performance in most domains (episodic long-term memory, rho = 0....
Parkinson’s disease (PD) patients frequently develop cognitive impairment. There is a need for brief...
OBJECTIVE To assess the relevance of Quantitative electroencephalography (qEEG) measures as outcomes...
OBJECTIVE: In Parkinson's Disease (PD), measures of non-dopaminergic systems involvement may reflect...
<b><i>Background:</i></b> Cognitive deficits in Parkinson's disease (PD) are heterogeneous and can b...
Background. Visuospatial dysfunction is among the first cognitive symptoms in Parkinson’s disease (P...
Background: Slowing of the electroencephalogram (EEG) is frequent in Parkinson's (PD) and Alzheimer'...
We sought to define quantitative electroencephalographic (EEG) measures as biomarkers of both early ...
OBJECTIVE: To assess the relevance of quantitative EEG (qEEG) measures as outcomes of disease severi...
OBJECTIVE To assess the relevance of Quantitative electroencephalography (qEEG) measures as outcomes...
Cognitive decline is common with the progression of Parkinson’s disease (PD). Different candidate bi...
Parkinson's Disease Dementia (PD-D) is one of the most important non-motor signs in advanced PD and ...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that is accompanied by a range ...
The pathophysiological mechanisms of Parkinson's disease (PD)-related dementia (PDD) are still poorl...
Background: QEEG could provide physiological biomarkers for changes over time in Parkinson\u27s dise...
Objective: We evaluated quantitative EEG (QEEG) measures as predictive biomarkers for the developmen...
Parkinson’s disease (PD) patients frequently develop cognitive impairment. There is a need for brief...
OBJECTIVE To assess the relevance of Quantitative electroencephalography (qEEG) measures as outcomes...
OBJECTIVE: In Parkinson's Disease (PD), measures of non-dopaminergic systems involvement may reflect...
<b><i>Background:</i></b> Cognitive deficits in Parkinson's disease (PD) are heterogeneous and can b...
Background. Visuospatial dysfunction is among the first cognitive symptoms in Parkinson’s disease (P...
Background: Slowing of the electroencephalogram (EEG) is frequent in Parkinson's (PD) and Alzheimer'...
We sought to define quantitative electroencephalographic (EEG) measures as biomarkers of both early ...
OBJECTIVE: To assess the relevance of quantitative EEG (qEEG) measures as outcomes of disease severi...
OBJECTIVE To assess the relevance of Quantitative electroencephalography (qEEG) measures as outcomes...
Cognitive decline is common with the progression of Parkinson’s disease (PD). Different candidate bi...
Parkinson's Disease Dementia (PD-D) is one of the most important non-motor signs in advanced PD and ...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that is accompanied by a range ...
The pathophysiological mechanisms of Parkinson's disease (PD)-related dementia (PDD) are still poorl...
Background: QEEG could provide physiological biomarkers for changes over time in Parkinson\u27s dise...
Objective: We evaluated quantitative EEG (QEEG) measures as predictive biomarkers for the developmen...
Parkinson’s disease (PD) patients frequently develop cognitive impairment. There is a need for brief...
OBJECTIVE To assess the relevance of Quantitative electroencephalography (qEEG) measures as outcomes...
OBJECTIVE: In Parkinson's Disease (PD), measures of non-dopaminergic systems involvement may reflect...